Research and analysis

Genetically Modified Organisms: ILiAD Biotechnologies, LLC (21/R53/01)

Inviting representation on an application from ILiAD Biotechnologies to release a genetically modified organism, reference 21/R53/01.

Documents

Part A1: Information required under Schedule 1 of the Genetically Modified Organisms (Deliberate Release) Regulations 2002 (as amended)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Part B: Information about the release application to be included on the public register

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Consent letter

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Consent documents for ILiAD Biotechnologies, LLC to release genetically modified organisms for research purposes.

Each consent granted includes:

  • consent letter (confirming consent and outlining any conditions)
  • part A (1 - 6): information required under schedule 1 of the Genetically Modified Organisms (Deliberate Release) regulations 2002
  • part B: information about the release application to be included on the public register

Updates to this page

Published 26 May 2021
Last updated 31 August 2021 + show all updates
  1. Consent has been granted.

  2. First published.

Sign up for emails or print this page